Lymphoma, Follicular
Item
histologically confirmed follicular lymphoma
boolean
C0024301 (UMLS CUI [1])
CD20 antigen positive
Item
cd20+ at time of diagnosis or subsequently
boolean
C3888518 (UMLS CUI [1])
rituximab
Item
more than 4 weeks since prior rituximab
boolean
C0393022 (UMLS CUI [1])
cancer treatment | Nitrosourea | Mitomycin-c
Item
more than 3 weeks since prior anticancer therapy (6 weeks for nitrosourea or mitomycin c)
boolean
C0920425 (UMLS CUI [1])
C0028210 (UMLS CUI [2])
C0002475 (UMLS CUI [3])
major surgery
Item
more than 4 weeks since prior major surgery
boolean
C0679637 (UMLS CUI [1])
Investigational New Drugs
Item
more than 2 weeks since prior investigational drugs
boolean
C0013230 (UMLS CUI [1])
Lymphoma, AIDS-Related
Item
aids-related lymphoma
boolean
C0085090 (UMLS CUI [1])
Central Nervous System Involvement | Central Nervous System Involvement Evidence of
Item
history or evidence of cns involvement
boolean
C4050309 (UMLS CUI [1])
C4050309 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
known hiv positivity
boolean
C0019699 (UMLS CUI [1])
Illness Serious Study Subject Participation Status Exclusion | Mental disorder Serious Study Subject Participation Status Exclusion
Item
serious medical or psychiatric illness that would preclude study participation
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C2828389 (UMLS CUI [1,4])
C0004936 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C2828389 (UMLS CUI [2,4])
Myocardial Infarction
Item
myocardial infarction within the past 6 months
boolean
C0027051 (UMLS CUI [1])
Congestive heart failure | Angina control - poor | Ventricular arrhythmia Severe Uncontrolled | Acute myocardial ischemia Evidence Electrocardiography | Conduction system abnormalities
Item
congestive heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or ecg evidence of acute ischemia or active conduction system abnormalities
boolean
C0018802 (UMLS CUI [1])
C0421196 (UMLS CUI [2])
C0085612 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0205318 (UMLS CUI [3,3])
C0746731 (UMLS CUI [4,1])
C3887511 (UMLS CUI [4,2])
C1623258 (UMLS CUI [4,3])
C0151236 (UMLS CUI [5])
Hypersensitivity rituximab | Hypersensitivity bortezomib | Hypersensitivity Boron | Hypersensitivity Mannitol
Item
known hypersensitivity to rituximab, bortezomib, boron, or mannitol
boolean
C0020517 (UMLS CUI [1,1])
C0393022 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1176309 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0006030 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0024730 (UMLS CUI [4,2])
Transplantation of autologous hematopoietic stem cell | Allogeneic Hematopoietic Stem Cell Transplantation
Item
prior autologous or allogeneic stem cell transplantation
boolean
C1831743 (UMLS CUI [1])
C1705576 (UMLS CUI [2])
Radioimmunoconjugates | Murine-Derived Monoclonal Antibodies Exposure to
Item
prior radioimmunoconjugate therapy or prior exposure to murine antibodies
boolean
C0243019 (UMLS CUI [1])
C2916903 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
Teleradiotherapy Bone Marrow Percentage
Item
prior external-beam irradiation to > 25% of active bone marrow
boolean
C0419095 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])